Conference on gram-positive bacteria and their infections
2024 International Conference on Gram Positive Pathogens
This conference brings together scientists to share ideas and solutions about infections caused by certain bacteria, like Clostridioides difficile, so they can work together to find better ways to fight these germs and improve treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10996362 on NIH RePORTER |
What this research studies
The International Conference on Gram-Positive Pathogens (ICGPP) gathers scientists to discuss and share research on gram-positive bacteria, which are responsible for various infections. This event allows researchers at all career stages to exchange ideas and strategies related to antibiotic resistance and the biological functions of these pathogens. Participants will explore topics such as protein secretion, cell wall biosynthesis, and the growing threat of infections like Clostridioides difficile. The conference aims to enhance collaboration and innovation in tackling the challenges posed by these bacteria.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals affected by infections caused by gram-positive bacteria, including those with antibiotic-associated colitis.
Not a fit: Patients with infections caused by gram-negative bacteria may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this conference could lead to improved understanding and strategies for managing infections caused by gram-positive pathogens.
How similar studies have performed: Previous conferences on similar topics have successfully fostered collaboration and innovation in the field, indicating a positive trend in addressing these health challenges.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Bose, Jeffrey Lee — University of Kansas Medical Center
- Study coordinator: Bose, Jeffrey Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.